MX9703025A - Proceso para preparar levobupivacaina y sus analogos. - Google Patents

Proceso para preparar levobupivacaina y sus analogos.

Info

Publication number
MX9703025A
MX9703025A MX9703025A MX9703025A MX9703025A MX 9703025 A MX9703025 A MX 9703025A MX 9703025 A MX9703025 A MX 9703025A MX 9703025 A MX9703025 A MX 9703025A MX 9703025 A MX9703025 A MX 9703025A
Authority
MX
Mexico
Prior art keywords
analogues
levobupivacaine
amidation
alkylation
preparing
Prior art date
Application number
MX9703025A
Other languages
English (en)
Inventor
Hooshang Shahriari Zavareh
Fraham Anthony Charles Frampto
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9421478A external-priority patent/GB9421478D0/en
Priority claimed from GBGB9504925.0A external-priority patent/GB9504925D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of MX9703025A publication Critical patent/MX9703025A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un proceso para preparar levobupivacaína, bupivacaína racémica u otro análogo N-alquilo de la misma, que comprende clorar el clorhidrato del ácido pipecolico, amidacion del clorhidrato del cloruro de pipecolilo resultante en solvente, sin aislamiento, con 2,6-dimetianilina y alquilacion del 2,6-xiliduro del ácido pipecolico resultante. Alternativamente, la alquilacion puede ser seguida por la amidacion.
MX9703025A 1994-10-25 1995-10-23 Proceso para preparar levobupivacaina y sus analogos. MX9703025A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9421478A GB9421478D0 (en) 1994-10-25 1994-10-25 Process and compounds
GBGB9504925.0A GB9504925D0 (en) 1995-03-10 1995-03-10 Process for preparing analgesic agents
PCT/GB1995/002514 WO1996012700A1 (en) 1994-10-25 1995-10-23 Process for preparing levobupivacaine and analogues thereof

Publications (1)

Publication Number Publication Date
MX9703025A true MX9703025A (es) 1997-10-31

Family

ID=26305864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703025A MX9703025A (es) 1994-10-25 1995-10-23 Proceso para preparar levobupivacaina y sus analogos.

Country Status (12)

Country Link
US (1) US5777124A (es)
EP (1) EP0788481B1 (es)
JP (1) JP4118946B2 (es)
AT (1) ATE248148T1 (es)
AU (1) AU694569B2 (es)
CA (1) CA2200356C (es)
DE (1) DE69531624T2 (es)
DK (1) DK0788481T3 (es)
ES (1) ES2203645T3 (es)
MX (1) MX9703025A (es)
PT (1) PT788481E (es)
WO (1) WO1996012700A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247729B2 (en) 2001-09-10 2007-07-24 Mercian Corporation Method for producing pipecolamide derivative
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US7683175B2 (en) * 2005-06-06 2010-03-23 Navinta, Llc Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2009535327A (ja) * 2006-04-25 2009-10-01 ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド ロピバカイン塩酸塩無水物およびその調製
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
KR100844336B1 (ko) 2007-01-16 2008-07-07 하나제약 주식회사 레보부피바카인 및 이의 염산염의 신규한 제조방법
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
ATE555094T1 (de) * 2008-01-15 2012-05-15 Pharmathen Sa Verfahren zur herstellung von pipecol-2-säure-2', 6'-xylidid als zwischenprodukt für die herstellung von lokalanästhetika
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102558030A (zh) * 2010-12-11 2012-07-11 山东方明药业股份有限公司 1-n-(2，6-二甲基苯基)-2-哌啶甲酰胺的合成
CN103086954A (zh) * 2013-02-04 2013-05-08 山东省医药工业研究所 一种制备罗哌卡因的方法
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
CN104003930B (zh) * 2014-06-13 2016-06-08 山东金诃药物研究开发有限公司 一种盐酸罗哌卡因的制备方法
CN105418489A (zh) * 2016-01-22 2016-03-23 江苏宝众宝达药业有限公司 一种布比卡因的合成方法
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
CN109438331A (zh) * 2018-09-20 2019-03-08 山东科源制药股份有限公司 一种制备罗哌卡因中间体的方法
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CN111548303A (zh) * 2020-06-28 2020-08-18 山东美泰医药有限公司 一种盐酸左布比卡因的杂质及其制备和分析方法
CN112939848B (zh) * 2021-02-25 2022-07-01 浙江工业大学 一种布比卡因及其中间体(s)-2-哌啶甲酸的制备方法
WO2023215604A1 (en) 2022-05-05 2023-11-09 Pfof Llc Anesthetic nerve block and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6803337A (es) * 1967-03-20 1968-09-23
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide

Also Published As

Publication number Publication date
ES2203645T3 (es) 2004-04-16
CA2200356C (en) 2007-07-31
DE69531624D1 (de) 2003-10-02
PT788481E (pt) 2004-01-30
ATE248148T1 (de) 2003-09-15
AU3704995A (en) 1996-05-15
AU694569B2 (en) 1998-07-23
JP4118946B2 (ja) 2008-07-16
JPH10507748A (ja) 1998-07-28
DK0788481T3 (da) 2003-12-01
US5777124A (en) 1998-07-07
CA2200356A1 (en) 1996-05-02
EP0788481A1 (en) 1997-08-13
WO1996012700A1 (en) 1996-05-02
EP0788481B1 (en) 2003-08-27
DE69531624T2 (de) 2004-06-17

Similar Documents

Publication Publication Date Title
MX9703025A (es) Proceso para preparar levobupivacaina y sus analogos.
NO961686L (no) Heteroarylpiperidiner, pyrrolidiner og piperaziner og deres anvendelse som antipsykotika og analgetika
RU97102050A (ru) Гетероциклические антагонисты тахикининовых рецепторов
HUT63384A (en) Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
HRP960592A2 (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
CA2291170A1 (en) Processes and intermediates for resolving piperidyl acetamide stereoisomers
CA2208522A1 (en) Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
TR199701362T1 (xx) Ropivakain hidroklor�r monohidrat�n haz�rlanmas�nda yeni i�lem.
MY103990A (en) 4-aryl-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof.
SG49078A1 (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
NO20002450L (no) Sammenstilling av aktive bestanddeler, særlig tetrahydropyridiner og acetylcholinesterase-inhiberende midler, for behandling av senil demens av Alzheimer-type
NO307757B1 (no) Uretanholdige aminosteroidforbindelser, farmasøytisk preparat samt anvendelse
DE50003759D1 (de) Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
BG104604A (en) Process for the preparation of paroxetin hydrochloride
BR9707943A (pt) Processo para a preparação de uma glutarimida composto glutarimida utilização de uma glutarimida e processo para a preparação de uma piperidina 3,3-dissubstituída
EP0417746A3 (en) N-azabicyclo/3.3.0/octane amides of aromatic acids
NO941134D0 (no) 1,2,5,6-tetrahydropyridin-derivat, fremgangsmåte for dets fremstilling, og dets terapeutiske anvendelser
ZA9711583B (en) Process for the preparation of a tetrahydropyridine derivative.
DE69203192T2 (de) Verfahren zur Herstellung von N-Ethylhydroxylamin-Hydrochlorid.
MXPA02003516A (es) Clorihidrato de n-[3-[[2-(3,4-dimetoxifenil)etil]amino[propil]-4-nitrobenzamida polimorfico.
AU2002356979A8 (en) Method of producing n-((2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl)-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof